Plenary Sessions

​​​​​​​​​​​​​​The AD/PDTM 2017 Plenary Speakers are:

Wednesday, March 29, 2017​ -16:30 -18:00

GENE SILENCING THERAPY FOR HUMAN NEURODEGENERATIVE DISEASE
Prof. Don Cleveland, USA
Head, Laboratory for Cell Biology, Ludwig Institute for Cancer Research
Distinguished Professor and Chair, Dept. of Cellular and Molecular Medicine, Univ. of California
San Diego​, CA

TRANSMISSION OF Α-SYNUCLEIN STRAINS IN SYNUCLEINOPATHIES​
Prof. Virginia Lee, USA​
Perelman School of Medicine at the University of Pennsylvania
The John H. Ware 3rd Professor in Alzheimer's Research
Director, Center for Neurodegenerative Disease Research and
Marian S. Ware Alzheimer Program
​Philadelphia, PA​

THURSDAY, MARCH 30, 2017​ -08:30 - 09:00

APOE, SYNAPSES, AND ALZHEIMER'S DISEASE
Prof. Tom Sudhof, USA - 2013 Nobel Prize in Physiology or Medicine 
Avram Goldstein Professor, Dept. of Molecular & Cellular Physiology, Stanford University School of Medicine
Stanford CA


FRIDAY, MARCH 31, 2017​ -08:30 - 09:00

​CURRENT DEVELOPMENTS IN THE TREATMENT OF PARKINSON'S DISEASE – FROM DISEASE MODIFICATION TO PREVENTION?
Prof. Werner Poewe, Austria
Director Department of Neurology, Innsbruck Medical University
Innsbruck 

SATURDAY, APRIL 1, 2017​​ - 08:30 -09:00

STAGING PATHOLOGY WITH PET​
Prof. Keith Johnson, USA
Massachusetts General Hospital 
Boston, MA​​

SUNDAY APRIL 2, 2017​​ -08:30​ -09:00

BLOOD BRAIN BARRIER DYSFUNCTION, NEURODEGENERATION AND ALZHEIMER'S DISEASE 
Prof. Berislav V. Zlokovic, USA​
Keck School of Medicine, Zilkha Neurogenetic Institute, University of Southern California
Los Angeles, CA​


AD/PD™ Facebook
AD/PD™ Twitter
AD/PD™ Network

Keep Me Updated